Axsome Therapeutics Readies Auvelity Alzheimer's Agitation Launch, Expands CNS Pipeline

Impact · against what's priced in

Axsome is entering a massive, underserved market for Alzheimer's agitation with a drug already possessing high payer coverage and a proven run rate in MDD. The aggressive doubling of the sales force and an increased $8 billion peak sales target suggest a significant growth inflection point not yet fully realized in the valuation.

AXSM+0.70: No priced-in read yet

Axsome Therapeutics Readies Auvelity Alzheimer's Agitation Launch, Expands CNS Pipeline

What matters in this story

HCLTech verzeichnet ein starkes zweites Quartal, das von Auftragseingängen in Rekordhöhe von 3,3 Mrd. US-Dollar getragen wurde

Axsome Therapeutics Readies Auvelity Alzheimer's Agitation Launch, Expands CNS Pipeline

What matters in this story

HCLTech verzeichnet ein starkes zweites Quartal, das von Auftragseingängen in Rekordhöhe von 3,3 Mrd. US-Dollar getragen wurde

How each ticker is affected

Track these names every morning.

Robbins LLP Reminds Sprout Social, Inc. Investors that the Securities Fraud Class Action Beat Motion to Dismiss Paving the Way for Litigation to Continue

Robbins LLP Reminds GoDaddy Inc. Stockholders of the October 20, 2026 Lead Plaintiff Deadline - GDDY Investors Should Contact the Firm for More Information

ArkBio Announces FDA Clearance to Initiate Phase II Trial of AK0406 for Influenza Prevention

Did You Lose Money Investing in Qfin Holdings, Inc.? Robbins LLP Reminds QFIN Investors with Large Losses to Contact the Firm for Information About Leading the Class Action Lawsuit

Axsome Therapeutics Readies Auvelity Alzheimer's Agitation Launch, Expands CNS Pipeline

What matters in this story

Next reads from the same story arc

HCLTech verzeichnet ein starkes zweites Quartal, das von Auftragseingängen in Rekordhöhe von 3,3 Mrd. US-Dollar getragen wurde

Axsome Therapeutics Readies Auvelity Alzheimer's Agitation Launch, Expands CNS Pipeline

What matters in this story

Next reads from the same story arc

HCLTech verzeichnet ein starkes zweites Quartal, das von Auftragseingängen in Rekordhöhe von 3,3 Mrd. US-Dollar getragen wurde

How each ticker is affected

Track these names every morning.

Robbins LLP Reminds Sprout Social, Inc. Investors that the Securities Fraud Class Action Beat Motion to Dismiss Paving the Way for Litigation to Continue

Robbins LLP Reminds GoDaddy Inc. Stockholders of the October 20, 2026 Lead Plaintiff Deadline - GDDY Investors Should Contact the Firm for More Information

ArkBio Announces FDA Clearance to Initiate Phase II Trial of AK0406 for Influenza Prevention

Did You Lose Money Investing in Qfin Holdings, Inc.? Robbins LLP Reminds QFIN Investors with Large Losses to Contact the Firm for Information About Leading the Class Action Lawsuit